Korean stem cell treatment technology acquired approval in Japan for the first time
R-Japan Co., Ltd., a Japanese affiliated company of Nature Cell, announced on the 11th that Nishihara Medical Clinic acquired approval of stem cell treatment for critical limb ischemia diseases, which includes Burger’s disease, from the Japanese Ministry of Health, Labour, and Welfare, led by Bio...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
